[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
A phase 2 trial of HER2 PET in Breast cancer and HER2-positive gastric cancer, run by Karolinska University Hospital, with a status the registry has not verified recently.
Overview
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors is a phase 2 interventional study registered as NCT05619016 by Karolinska University Hospital, with 72 participants planned, started 2022-11-23 and due to reach its primary completion in 2025-12-31. Interventions recorded: [68Ga]Ga-ABY-025 PET, Biopsy and analysis of HER2 expression. Conditions recorded: Esophageal Neoplasms, Gastric Neoplasms Malignant, Breast Cancer, HER2-positive Gastric Cancer.
Linked to the technology HER2 PET because the registry names it ("her2 pet") among its interventions and Breast cancer and HER2-positive gastric cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialOptimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging
Shares HER2 PET, Breast cancer (all types) and the tag pipeline.
- TrialTherapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric Cancer
Shares HER2-positive gastric cancer and the tag pipeline.
- TrialHER2 Targeted Molecular Imaging in mBC and Other Metastatic Solid Carcinomas Using 68Ga-ABS011
Shares HER2 PET and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.